Companion Diagnostics Market Size, Trends, and Growth Analysis 2026-2033 The Companion Diagnostics industry is witnessing robust growth driven by rapid advancements in personalized medicine and precision therapeutics. This market’s expansion underscores its critical role in enhancing targeted treatment efficacy, optimizing drug development, and improving patient outcomes across diverse healthcare sectors. Market Size and Overview Companion Diagnostics Market is estimated to be valued at USD 9.86 Bn in 2026 and is expected to reach USD 22.48 Bn in 2033, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033. #MolecularDiagnostics #CancerDiagnostics #OncologyDiagnostics #BiomarkerTesting #DiagnosticTesting